IGF1 and type 2 diabetes mellitus: Moreover, hypoproteinemia and low body mass index lead to decreased synthesis of insulin-like growth factor-1 (IGF-1) in patients with T2DM, which inhibits osteoblast proliferation, leading to decreased osteoblast numbers, prolonged osteoclast lifespan, increased bone resorption, and decreased bone remodeling29.